㈱レグイミューン
Taiwan, TW · 4 known investors
Find your way into ㈱レグイミューン
Sign up to see every warm intro you have to ㈱レグイミューン
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ㈱レグイミューン team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RegiMMune is a biotech company with an investor relations section providing financial reports and corporate governance documents.
Founders & leadership
SY
Steve YangChief Executive Officer
RN
Reiko NamikawaExecutive Vice President, Clinical Development
Board
KK
Kenzo KosudaChairman; Member of the Board of Directors
Investors · 4
Frequently asked questions
- What does ㈱レグイミューン do?
- RegiMMune is a biotech company with an investor relations section providing financial reports and corporate governance documents.
- Who are ㈱レグイミューン's investors?
- ㈱レグイミューン's investors include DBJ Capital, Hiroshima Venture Capital Co. Ltd., Miyako Capital, Oita Venture Capital.
- Where is ㈱レグイミューン headquartered?
- ㈱レグイミューン is headquartered in Taiwan, TW.